Orthofix Medical Inc. (OFIX)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 80M 160M 240M Q1 '10: 138.8M Q2 '10: 142.8M Q3 '10: 138.9M Q4 '10: 143.8M Q1 '11: 139.2M Q2 '11: 116.7M Q3 '11: 117.3M Q4 '11: 118.6M Q1 '12: 108.9M Q2 '12: 113.4M Q3 '12: 107.9M Q4 '12: 115.6M Q1 '13: 102.3M Q2 '13: 97.6M Q3 '13: 91.8M Q4 '13: 105.9M Q1 '14: 100M Q2 '14: 101M Q3 '14: 101M Q4 '14: 100.3M Q1 '15: 89.8M Q2 '15: 101M Q3 '15: 101.2M Q4 '15: 104.6M Q1 '16: 98.7M Q2 '16: 104.1M Q3 '16: 98.5M Q4 '16: 108.5M Q1 '17: 102.7M Q2 '17: 108.9M Q3 '17: 105.2M Q4 '17: 116.9M Q1 '18: 108.7M Q2 '18: 111.5M Q3 '18: 111.7M Q4 '18: 121.1M Q1 '19: 109.1M Q2 '19: 115.8M Q3 '19: 113.5M Q4 '19: 121.5M Q1 '20: 104.8M Q2 '20: 73.1M Q3 '20: 111M Q4 '20: 117.6M Q1 '21: 105.6M Q2 '21: 121.4M Q3 '21: 112.4M Q4 '21: 125.1M Q1 '22: 106.4M Q2 '22: 118.1M Q3 '22: 114M Q4 '22: 122.2M Q1 '23: 175.2M Q2 '23: 187M Q3 '23: 184M Q4 '23: 200.4M Q1 '24: 188.6M Q2 '24: 198.6M Q3 '24: 196.6M Q4 '24: 215.7M Q1 '25: 193.6M Q2 '25: 203.1M Q3 '25: 205.6M Q4 '25: 219.9M Q1 '26: 196.7M Q2 '26: 210.9M Q3 '10 Q4 '12 Q1 '15 Q2 '17 Q3 '19 Q4 '21 Q1 '24 Q2 '26

Gross Profit Quarterly

0 60M 120M 180M Q1 '10: 106.1M Q2 '10: 108.8M Q3 '10: 106.6M Q4 '10: 111.1M Q1 '11: 105.8M Q2 '11: 93.5M Q3 '11: 93.5M Q4 '11: 91.3M Q1 '12: 87.6M Q2 '12: 85.9M Q3 '12: 83.5M Q4 '12: 88.9M Q1 '13: 76.4M Q2 '13: 75.8M Q3 '13: 66.7M Q4 '13: 71.8M Q1 '14: 73.2M Q2 '14: 75.6M Q3 '14: 75.7M Q4 '14: 78.8M Q1 '15: 70.4M Q2 '15: 79M Q3 '15: 77.3M Q4 '15: 83.2M Q1 '16: 76.5M Q2 '16: 81.6M Q3 '16: 78.6M Q4 '16: 85.2M Q1 '17: 80.2M Q2 '17: 85.8M Q3 '17: 81.5M Q4 '17: 93.3M Q1 '18: 84.6M Q2 '18: 88.7M Q3 '18: 87.7M Q4 '18: 95.5M Q1 '19: 85.4M Q2 '19: 90M Q3 '19: 88.6M Q4 '19: 95.3M Q1 '20: 81.4M Q2 '20: 50M Q3 '20: 84.7M Q4 '20: 88.5M Q1 '21: 79.7M Q2 '21: 94M Q3 '21: 84.1M Q4 '21: 91.8M Q1 '22: 78.1M Q2 '22: 86.5M Q3 '22: 83.4M Q4 '22: 89.2M Q1 '23: 110.3M Q2 '23: 119.6M Q3 '23: 119.8M Q4 '23: 136.6M Q1 '24: 127.2M Q2 '24: 134.7M Q3 '24: 135.1M Q4 '24: 148.8M Q1 '25: 121.6M Q2 '25: 139.5M Q3 '25: 148.5M Q4 '25: 156.3M Q1 '26: 139.5M Q2 '26: 149.7M Q3 '10 Q4 '12 Q1 '15 Q2 '17 Q3 '19 Q4 '21 Q1 '24 Q2 '26

Operating Income Quarterly

-75M -50M -25M 0 25M 50M 75M Q2 '10: 21.2M Q3 '10: 19M Q1 '11: -26.1M Q2 '11: 19.4M Q3 '11: 23.6M Q4 '11: 8.2M Q1 '12: 17.9M Q2 '12: 14.3M Q3 '12: 18.8M Q4 '12: 26.5M Q1 '13: 6.1M Q2 '13: 6.9M Q3 '13: -14.1M Q4 '13: -10.1M Q1 '14: -29K Q2 '14: 6.7M Q3 '14: 6.5M Q4 '14: 4M Q1 '15: -7.2M Q2 '15: 4.9M Q3 '15: 4.1M Q4 '15: 7.4M Q1 '16: 7.1M Q2 '16: -2.7M Q3 '16: 9.3M Q4 '16: 7.4M Q1 '17: 5.9M Q2 '17: 8M Q3 '17: 9M Q4 '17: 17.9M Q1 '18: 7.9M Q2 '18: 5.9M Q3 '18: 3.9M Q4 '18: 12.4M Q1 '19: -4.4M Q2 '19: 451K Q3 '19: -18.9M Q4 '19: 4.1M Q1 '20: 6.9M Q2 '20: -21M Q3 '20: 4.2M Q4 '20: 3.7M Q1 '21: -2.9M Q2 '21: 4.3M Q3 '21: -313K Q4 '21: -9.4M Q1 '22: -3.1M Q2 '22: 6.6M Q3 '22: -5.8M Q4 '22: -11M Q1 '23: -59.7M Q2 '23: -36.6M Q3 '23: -24.4M Q4 '23: -18.3M Q1 '24: -29.3M Q2 '24: -24.9M Q3 '24: -18.9M Q4 '24: -11.5M Q1 '25: -48.9M Q2 '25: -16M Q3 '25: -17M Q4 '25: 494K Q1 '26: -14.4M Q2 '26: -8.1M Q2 '12 Q2 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

Net Income Quarterly

-75M -50M -25M 0 25M 50M 75M Q1 '10: 17.5M Q2 '10: 10.2M Q3 '10: 8.5M Q4 '10: 8M Q1 '11: -41.5M Q2 '11: 10M Q3 '11: 12.4M Q4 '11: 7.9M Q1 '12: 9.4M Q2 '12: 7.3M Q3 '12: 5M Q4 '12: 23M Q1 '13: 3.4M Q2 '13: -3M Q3 '13: -18.8M Q4 '13: -10.4M Q1 '14: -2.5M Q2 '14: -683K Q3 '14: 452K Q4 '14: -5.8M Q1 '15: -8.4M Q2 '15: 3.6M Q3 '15: -1.4M Q4 '15: 3.4M Q1 '16: 3.8M Q2 '16: -7.4M Q3 '16: 9.9M Q4 '16: -3.2M Q1 '17: -2.7M Q2 '17: 3.9M Q3 '17: 3.5M Q4 '17: 1.6M Q1 '18: 5.2M Q2 '18: 925K Q3 '18: -1.2M Q4 '18: 8.9M Q1 '19: 897K Q2 '19: -547K Q3 '19: -40.5M Q4 '19: 11.7M Q1 '20: 25.7M Q2 '20: -18.4M Q3 '20: 4.7M Q4 '20: -9.4M Q1 '21: -5.8M Q2 '21: 2.4M Q3 '21: -2.2M Q4 '21: -32.8M Q1 '22: -4.5M Q2 '22: 2.5M Q3 '22: -10.7M Q4 '22: -7.1M Q1 '23: -60.9M Q2 '23: -39.4M Q3 '23: -28.9M Q4 '23: -22.2M Q1 '24: -36M Q2 '24: -33.4M Q3 '24: -27.4M Q4 '24: -29.1M Q1 '25: -53.1M Q2 '25: -14.1M Q3 '25: -22.8M Q4 '25: -2.2M Q1 '26: -20.9M Q2 '26: -15.8M Q3 '10 Q4 '12 Q1 '15 Q2 '17 Q3 '19 Q4 '21 Q1 '24 Q2 '26

Cost of Revenue Quarterly

-25M 0 25M 50M 75M Q1 '10: 32.7M Q2 '10: 34.1M Q3 '10: 32.3M Q4 '10: -2M Q1 '11: 33.4M Q2 '11: 23.2M Q3 '11: 23.9M Q4 '11: 27.3M Q1 '12: 21.4M Q2 '12: 27.5M Q3 '12: 24.4M Q4 '12: 26.8M Q1 '13: 25.8M Q2 '13: 21.9M Q3 '13: 25.1M Q4 '13: 34.1M Q1 '14: 26.8M Q2 '14: 25.4M Q3 '14: 25.3M Q4 '14: 21.5M Q1 '15: 19.3M Q2 '15: 21.9M Q3 '15: 23.9M Q4 '15: 21.4M Q1 '16: 22.1M Q2 '16: 22.5M Q3 '16: 19.9M Q4 '16: 23.3M Q1 '17: 22.6M Q2 '17: 23.2M Q3 '17: 23.7M Q4 '17: 23.6M Q1 '18: 24.1M Q2 '18: 22.8M Q3 '18: 24M Q4 '18: 25.6M Q1 '19: 23.7M Q2 '19: 25.8M Q3 '19: 24.9M Q4 '19: 26.2M Q1 '20: 23.4M Q2 '20: 23.2M Q3 '20: 26.2M Q4 '20: 29.1M Q1 '21: 25.9M Q2 '21: 27.4M Q3 '21: 28.3M Q4 '21: 33.3M Q1 '22: 28.3M Q2 '22: 31.6M Q3 '22: 30.6M Q4 '22: 33.1M Q1 '23: 64.9M Q2 '23: 67.5M Q3 '23: 64.2M Q4 '23: 63.8M Q1 '24: 61.4M Q2 '24: 63.9M Q3 '24: 61.6M Q4 '24: 66.8M Q1 '25: 72M Q2 '25: 63.6M Q3 '25: 57.1M Q4 '25: 63.6M Q1 '26: 57.2M Q2 '26: 61.2M Q3 '10 Q4 '12 Q1 '15 Q2 '17 Q3 '19 Q4 '21 Q1 '24 Q2 '26

Operating Cash Flow Quarterly

-40M -20M 0 20M 40M 60M Q3 '10: 10.2M Q1 '11: 18.8M Q2 '11: 4.6M Q3 '11: 16.2M Q4 '11: 25.1M Q1 '12: 49M Q2 '12: 8.8M Q3 '12: 10.6M Q1 '13: 15.1M Q2 '13: 19.1M Q3 '13: 17.8M Q4 '13: 15.1M Q1 '14: -10.2M Q2 '14: 28.1M Q3 '14: 18.1M Q4 '14: 15.2M Q1 '15: 2.5M Q2 '15: 6.4M Q3 '15: 17.6M Q4 '15: 17.1M Q1 '16: 4.6M Q2 '16: 16.7M Q3 '16: 17M Q4 '16: 20.7M Q1 '17: -10.9M Q2 '17: 6.3M Q3 '17: 13.8M Q4 '17: 29.8M Q1 '18: -3.6M Q2 '18: 16.6M Q3 '18: 15.8M Q4 '18: 21.1M Q1 '19: -1M Q2 '19: 9.4M Q3 '19: 11.7M Q4 '19: 11.9M Q1 '20: 12.5M Q2 '20: 17.6M Q3 '20: 21.9M Q4 '20: 22.3M Q1 '21: 2.4M Q2 '21: -2.2M Q3 '21: 6.4M Q4 '21: 11.8M Q1 '22: -7.7M Q2 '22: -4.9M Q3 '22: -1.3M Q4 '22: 2.3M Q1 '23: -34M Q2 '23: -5.5M Q3 '23: 477K Q4 '23: -6.7M Q1 '24: -18.6M Q2 '24: 9M Q3 '24: 11.7M Q4 '24: 23.7M Q1 '25: -18.4M Q2 '25: 11.6M Q3 '25: 12.4M Q4 '25: 27.7M Q1 '26: -17.6M Q2 '26: -6.2M Q1 '12 Q2 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

Free Cash Flow Quarterly

-60M -40M -20M 0 20M 40M 60M Q3 '10: 5M Q1 '11: 13.2M Q2 '11: -792K Q3 '11: 10.3M Q4 '11: 17M Q1 '12: 42.6M Q2 '12: 2.4M Q3 '12: 5.2M Q1 '13: 9M Q2 '13: 12.3M Q3 '13: 11.2M Q4 '13: 9.8M Q1 '14: -13.9M Q2 '14: 25.6M Q3 '14: 12.9M Q4 '14: 8.5M Q1 '15: -2.5M Q2 '15: -2M Q3 '15: 10.1M Q4 '15: 10.9M Q1 '16: -1.4M Q2 '16: 13.2M Q3 '16: 13.7M Q4 '16: 17.2M Q1 '17: -14.6M Q2 '17: 2.9M Q3 '17: 9.4M Q4 '17: 26.6M Q1 '18: -6.4M Q2 '18: 13.6M Q3 '18: 12M Q4 '18: 17.1M Q1 '19: -5.7M Q2 '19: 4.4M Q3 '19: 7.6M Q4 '19: 6.7M Q1 '20: 8.2M Q2 '20: 13.4M Q3 '20: 18.8M Q4 '20: 18.4M Q1 '21: -1.9M Q2 '21: -6.8M Q3 '21: 3.9M Q4 '21: 5.6M Q1 '22: -13M Q2 '22: -10.6M Q3 '22: -6.4M Q4 '22: -2.9M Q1 '23: -45.5M Q2 '23: -17.9M Q3 '23: -21.4M Q4 '23: -21.3M Q1 '24: -29.1M Q2 '24: -360K Q3 '24: 6.3M Q4 '24: 15.2M Q1 '25: -25.1M Q2 '25: 4.5M Q3 '25: 2.5M Q4 '25: 16.8M Q1 '26: -28.3M Q2 '26: -18.9M Q1 '12 Q2 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 15M 30M 45M Q2 '10: 17.9M Q3 '10: 17.8M Q1 '11: 17.9M Q2 '11: 18.5M Q3 '11: 18.9M Q1 '12: 19.1M Q2 '12: 19.2M Q3 '12: 19.5M Q1 '13: 19.7M Q2 '13: 19.3M Q3 '13: 18.1M Q1 '14: 18.2M Q2 '14: 18.6M Q3 '14: 18.8M Q1 '15: 18.7M Q2 '15: 19M Q3 '15: 18.9M Q1 '16: 18.8M Q2 '16: 18.1M Q3 '16: 18.4M Q1 '17: 18M Q2 '17: 18.3M Q3 '17: 18.6M Q1 '18: 18.9M Q2 '18: 18.8M Q3 '18: 18.6M Q1 '19: 19.2M Q2 '19: 18.8M Q3 '19: 19M Q1 '20: 19.3M Q2 '20: 19.2M Q3 '20: 19.4M Q1 '21: 19.5M Q2 '21: 19.9K Q3 '21: 19.8K Q1 '22: 19.9K Q2 '22: 20.1K Q3 '22: 20.1K Q1 '23: 35.7K Q2 '23: 36.8K Q3 '23: 37.2M Q1 '24: 37.7M Q2 '24: 38M Q3 '24: 38.5M Q1 '25: 39.2M Q2 '25: 39.5M Q3 '25: 39.8M Q1 '26: 40.5M Q2 '26: 40.9M Q2 '12 Q3 '14 Q1 '17 Q2 '19 Q3 '21 Q1 '24 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-4.50 -3.00 -1.50 0.00 1.50 3.00 4.50 Q4 '10: 2.48 Q1 '11: -0.51 Q2 '11: -0.54 Q3 '11: -0.36 Q4 '11: -0.38 Q1 '12: 2.11 Q2 '12: 1.94 Q3 '12: 1.53 Q4 '12: 2.28 Q1 '13: 1.97 Q2 '13: 1.44 Q3 '13: 0.15 Q4 '13: -1.60 Q1 '14: -1.92 Q2 '14: -1.80 Q3 '14: -0.74 Q4 '14: -0.47 Q1 '15: -0.78 Q2 '15: -0.55 Q3 '15: -0.64 Q4 '15: -0.15 Q1 '16: 0.50 Q2 '16: -0.10 Q3 '16: 0.51 Q4 '16: 0.15 Q1 '17: -0.20 Q2 '17: 0.42 Q3 '17: 0.07 Q4 '17: 0.33 Q1 '18: 0.75 Q2 '18: 0.59 Q3 '18: 0.33 Q4 '18: 0.71 Q1 '19: 0.49 Q2 '19: 0.41 Q3 '19: -1.66 Q4 '19: -1.52 Q1 '20: -0.25 Q2 '20: -1.18 Q3 '20: 1.20 Q4 '20: 0.13 Q1 '21: -1.49 Q2 '24: -3.19 Q3 '24: -3.13 Q4 '24: -3.29 Q1 '25: -3.69 Q2 '25: -3.17 Q3 '25: -3.03 Q4 '25: -2.33 Q1 '26: -1.50 Q2 '26: -1.53 Q1 '11 Q4 '12 Q3 '14 Q2 '16 Q1 '18 Q4 '19 Q3 '24 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.